Clinicians and researchers from around the world attended this week’s 8th International Forum on Mood and Anxiety disorders in Vienna, Austria to discuss the latest advances in the treatment of mood disorders. A wide range of topics were included in this year’s programme, highlighting the position of IFMAD in the congress calendar as a forum for breaking news, original thinking and debate.
Popularity: 1% [?]
Related posts:
- New Data Presented For SEROQUEL XRTM In Major Depressive Disorder And Generalised Anxiety Disorder
- AstraZeneca Presents New Depression And Anxiety Results For SEROQUEL XR
- AstraZeneca Presents New Depression And Anxiety Results For SEROQUEL XR
- Awareness Campaign – To Dispel Myths About Mood Disorders – Mood Disorders Association Of Ontario
- SEROQUEL XL® (quetiapine Fumarate Prolonged Release): New Depression And Anxiety Results Presented At IFMAD In Budapest
Comments
No Responses to “New Data, New Directions In Management Of Mood And Anxiety Disorders – 8th International Forum For Mood And Anxiety Disorders Congress”